Table 1 Subset of demographics and chemotherapy regimens for study participants receiving treatment for breast cancer
Treatment/demographic factor | Black participants N = 22 (30.6%) | White participants N = 50 (69.4%) | ||||||
|---|---|---|---|---|---|---|---|---|
Therapy regimen | TAC1 n = 10 (45%)2 | TC1 n = 6 (27%) | TCH1 n = 6 (27%) | Total n = 22 (100%) | TAC1 n = 29 (58%) | TC1 n = 15 (30%) | TCH1 n = 6(12%) | Total n = 50(100%) |
Age | 44.0 [3.4]3 | 47.0 [2.5] | 50.5 [2.9] | 46.6 [2.1] | 52.2 [1.7] | 57.1 [2.6] | 51.0 [5.2] | 53.5 [1.4] |
Income | ||||||||
 Less than $30,000 | 5 (23%) | 4 (18%) | 3 (14%) | 12 (55%) | 6 (12%) | 1 (2%) | 0 (0%) | 7 (14%) |
 $30,000–$59,999 | 3 (14%) | 2 (9%) | 3 (14%) | 8 (37%) | 5 (10%) | 1 (2%) | 0 (0%) | 6 (12%) |
 $60,000–$89,999 | 1 (4%) | 0 (0%) | 0 (0%) | 1 (4%) | 8 (16%) | 7 (14%) | 3 (6%) | 18 (36%) |
 $90,000+ | 1 (4%) | 0 (0%) | 0 (0%) | 1 (4%) | 10 (20%) | 6 (12%) | 3 (6%) | 19 (36%) |